Integral Ad Science (NASDAQ:IAS) Lowered to Market Perform Rating by Raymond James Financial

Raymond James Financial lowered shares of Integral Ad Science (NASDAQ:IAS) from an outperform rating to a market perform rating in a research note issued to investors on Thursday, MarketBeat.com reports.

A number of other brokerages have also recently issued reports on IAS. Barclays boosted their target price on shares of Integral Ad Science from $9.00 to $10.00 and gave the company an “equal weight” rating in a research report on Friday, August 8th. BMO Capital Markets set a $10.30 price objective on shares of Integral Ad Science and gave the stock a “market perform” rating in a research report on Wednesday. Stifel Nicolaus upped their price objective on shares of Integral Ad Science from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Tuesday, July 22nd. Craig Hallum cut shares of Integral Ad Science from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. Finally, Wall Street Zen raised shares of Integral Ad Science from a “hold” rating to a “buy” rating in a research report on Sunday, August 10th. One equities research analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $12.81.

Integral Ad Science Price Performance

NASDAQ:IAS opened at $10.22 on Thursday. Integral Ad Science has a one year low of $6.26 and a one year high of $13.62. The company has a market cap of $1.70 billion, a P/E ratio of 30.06, a P/E/G ratio of 1.46 and a beta of 1.57. The firm’s fifty day moving average price is $8.72 and its two-hundred day moving average price is $8.17.

Integral Ad Science (NASDAQ:IAS) last announced its earnings results on Thursday, August 7th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.03. The company had revenue of $149.20 million during the quarter, compared to analysts’ expectations of $143.02 million. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities research analysts expect that Integral Ad Science will post 0.26 earnings per share for the current year.

Insider Transactions at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 14,904 shares of the stock in a transaction dated Tuesday, July 8th. The shares were sold at an average price of $8.31, for a total value of $123,852.24. Following the completion of the transaction, the chief executive officer owned 379,316 shares of the company’s stock, valued at approximately $3,152,115.96. This represents a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Alexis Gil II sold 25,901 shares of the firm’s stock in a transaction that occurred on Wednesday, September 24th. The shares were sold at an average price of $10.18, for a total transaction of $263,672.18. Following the completion of the transaction, the chief accounting officer owned 145,140 shares of the company’s stock, valued at approximately $1,477,525.20. This trade represents a 15.14% decrease in their position. The disclosure for this sale can be found here. Insiders sold 60,974 shares of company stock valued at $553,313 in the last three months. Company insiders own 2.00% of the company’s stock.

Institutional Trading of Integral Ad Science

Institutional investors have recently modified their holdings of the business. American Century Companies Inc. bought a new stake in shares of Integral Ad Science in the first quarter worth $711,000. Delphi Management Inc. MA bought a new stake in shares of Integral Ad Science in the second quarter worth $539,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Integral Ad Science by 42.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 155,010 shares of the company’s stock valued at $1,618,000 after purchasing an additional 46,395 shares during the period. Envestnet Asset Management Inc. increased its position in Integral Ad Science by 165.6% during the 1st quarter. Envestnet Asset Management Inc. now owns 84,471 shares of the company’s stock valued at $681,000 after purchasing an additional 52,664 shares during the period. Finally, Bank of New York Mellon Corp increased its position in Integral Ad Science by 15.9% during the 1st quarter. Bank of New York Mellon Corp now owns 291,079 shares of the company’s stock valued at $2,346,000 after purchasing an additional 39,988 shares during the period. Institutional investors own 95.78% of the company’s stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.